The Medical Letter on Drugs and Therapeutics
FROM
ISSUE877
ISSUE877
August 21, 1992
Oral Mesalamine for Ulcerative Colitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Oral Mesalamine for Ulcerative Colitis
August 21, 1992 (Issue: 877)
An oral formulation of mesalamine (5-aminosalicylic acid, 5-ASA, Asacol - Proctor & Gamble), was recently approved by the US Food and Drug Administration (FDA) for treatment of mildly to moderately active ulcerative colitis; it has not been...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.